Strengths and limitations of remote pharmacovigilance audit
The emergence of COVID-19 and the economic consequences and travel restrictions that this pandemic has caused have led pharmaceutical companies to review their audit methods. Remote pharmacovigilance auditing has been implemented exponentially, but what are its Strengths and limitations? Strengths: Maintain audit planning (internal, contractors) in any circumstances (pandemic or other crisis situations…), more flexibility […]
